Talphera (NASDAQ:TLPH) Issues Earnings Results, Meets Estimates

Talphera (NASDAQ:TLPH) issued its earnings results on Wednesday. The company reported ($0.06) earnings per share for the quarter, hitting analysts’ consensus estimates of ($0.06), FiscalAI reports.

Talphera Stock Down 4.8%

Shares of NASDAQ TLPH traded down $0.07 during mid-day trading on Wednesday, reaching $1.40. 497,231 shares of the company were exchanged, compared to its average volume of 246,501. The stock has a market capitalization of $72.66 million, a P/E ratio of -4.52 and a beta of 0.69. The company’s 50-day simple moving average is $1.16 and its 200-day simple moving average is $0.95. Talphera has a twelve month low of $0.40 and a twelve month high of $1.57.

Wall Street Analyst Weigh In

A number of research analysts have recently commented on TLPH shares. Wall Street Zen raised shares of Talphera to a “hold” rating in a research report on Saturday. Zacks Research raised shares of Talphera to a “hold” rating in a report on Monday, June 8th. Weiss Ratings reiterated a “sell (d-)” rating on shares of Talphera in a research note on Friday, July 17th. HC Wainwright began coverage on Talphera in a report on Friday, June 5th. They set a “buy” rating and a $3.00 price target for the company. Finally, Westpark Capital assumed coverage on Talphera in a research report on Thursday, April 30th. They set a “buy” rating and a $3.00 price target on the stock. Two research analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus target price of $3.00.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of the stock. Nantahala Capital Management LLC lifted its holdings in Talphera by 75.3% during the 3rd quarter. Nantahala Capital Management LLC now owns 3,492,519 shares of the company’s stock worth $3,120,000 after purchasing an additional 1,500,000 shares during the last quarter. Cantor Fitzgerald L. P. bought a new stake in Talphera in the 4th quarter valued at $658,000. Renaissance Technologies LLC grew its holdings in Talphera by 412.6% in the 4th quarter. Renaissance Technologies LLC now owns 257,380 shares of the company’s stock valued at $293,000 after buying an additional 207,166 shares in the last quarter. Geode Capital Management LLC grew its holdings in Talphera by 107.0% in the 4th quarter. Geode Capital Management LLC now owns 342,987 shares of the company’s stock valued at $391,000 after buying an additional 177,294 shares in the last quarter. Finally, Diadema Partners LP bought a new position in Talphera during the 4th quarter worth $156,000. 37.67% of the stock is owned by institutional investors.

Talphera Company Profile

Talphera, Inc, a specialty pharmaceutical company, focuses on the development and commercialization of therapies for use in medically supervised settings. Its lead product candidate is Niyad, a lyophilized formulation of nafamostat, which is under an investigational device exemption as an anticoagulant for the extracorporeal circuit. It is also developing LTX-608, an anti-inflammatory and antiviral potential for the treatment of multiple conditions, including disseminated intravascular coagulation (DIC), acute respiratory distress syndrome (ARDS), and acute pancreatitis; Fedsyra, a pre-filled ephedrine syringe; and PFS-02, a pre-filled phenylephrine syringe.